Edesa Biotech, Inc.: insider trades · United States · SEC (Form 4)

Discover the full insider trade history of Edesa Biotech, Inc., a listed equity based in United States. Shares are listed on US US, under the authority of SEC (Form 4). Operating in the Healthcare sector, Edesa Biotech, Inc. has published 16 public disclosures. Market capitalisation: €17.6m. The latest transaction was disclosed on 30 June 2022 — Acquisition. Among the most active insiders: Nijhawan Pardeep. All data is openly available.